P. Chollet
- Oncology top 0.2%
- Cancer Treatment and Pharmacology 87
- HER2/EGFR in Cancer Research 28
- Colorectal Cancer Treatments and Studies 26
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies 79
- Pathology and Forensic Medicine top 0.5%
- Breast Lesions and Carcinomas 27
- Molecular Medicine top 1%
- Hepatology top 2%
-
- Estrogen and related hormone effects 15
- Chronic Lymphocytic Leukemia Research 10
-
- Advanced Breast Cancer Therapies 14
P. Chollet
233 papers receiving 8.2k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Oncology 5.1k
- Cancer Research 2.6k
- Pathology and Forensic Medicine 1.4k
- Molecular Medicine 310
- Hepatology 492
Countries citing papers authored by P. Chollet
This map shows the geographic impact of P. Chollet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Chollet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Chollet more than expected).
Fields of papers citing papers by P. Chollet
This network shows the impact of papers produced by P. Chollet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Chollet. The network helps show where P. Chollet may publish in the future.
Co-authorship network
The 25 scholars most cited alongside P. Chollet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 4 | |
| 2 | 2016 | 112 | |
| 3 | 2015 | 68 | |
| 4 | 2015 | 2 | |
| 5 | 2014 | 37 | |
| 6 | 2010 | 92 | |
| 7 | The development of non-specific surveillance in Mayotte and Reunion Islands in the context of the epidemic of influenza A(H1N1)2009. | 2010 | 3 |
| 8 | Exemestane as neoadjuvant hormonotherapy for locally advanced breast cancer: results of a phase II trial. | 2007 | 17 |
| 9 | 2007 | 7 | |
| 10 | 2006 | 48 | |
| 11 | 2006 | 39 | |
| 12 | 2003 | 64 | |
| 13 | 2003 | 32 | |
| 14 | Chrono-pharmacocinétique du 5-fluoro-uracile dans le traitement des cancers colorectaux métastatiques et indicateurs de réponse métabolique | 1999 | 1 |
| 15 | Pathological response to neoadjuvant chemotherapy Final results of a prospective randomized trial of 4AT vs 4AC as induction therapy in patients with operable breast cancer using Sataloff classification | 1999 | 12 |
| 16 | 1996 | 81 | |
| 17 | 1992 | 8 | |
| 18 | Comparison of Class II HLA antigen expression in normal and carcinomatous human breast cells. | 1985 | 11 |
| 19 | Application of cell electrophoretic methods (preparative and analytical) in demonstrating the surface heterogeneity of T-lymphocytes in man. | 1978 | 10 |
| 20 | Unchanged electrophoretic mobility in human cryopreserved lymphocytes. | 1977 | 2 |
About P. Chollet
P. Chollet is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 243 papers that have together received 8.5k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (87 papers), Breast Cancer Treatment Studies (79 papers), HER2/EGFR in Cancer Research (28 papers), Breast Lesions and Carcinomas (27 papers), Colorectal Cancer Treatments and Studies (26 papers), Estrogen and related hormone effects (15 papers), Advanced Breast Cancer Therapies (14 papers) and Chronic Lymphocytic Leukemia Research (10 papers). The work is most often cited by research in Oncology (5.1k citations), Cancer Research (2.6k citations) and Pathology and Forensic Medicine (1.4k citations). P. Chollet has collaborated with scholars based in France, Belgium and Italy. Frequent co-authors include Xavier Durando, Catherine Abrial, H. Curé, Françis Lévi, B Perpoint, Rachid Zidani, Marie‐Ange Mouret‐Reynier, Henri Roché, Frédérique Penault‐Llorca and J Dauplat. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, Cancer Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.